Activation of SREBP-1c alters lipogenesis and promotes tumor growth and metastasis in gastric cancer.

• SREBP-1c is oncogenic via fatty acid and lipid synthesis alters lipogenesis. • Fatty acid related metabolic synthetase is required for tumorigenesis. • Specific fatty acid of palmitic acid is a tumor suppressor gene in fatty acid metabolism. • Inhibition of SREBP-1c is a potential strategy in the treatment of Gastric cancer. Aggressively growing tumors are characterized by significant variations in metabolites, including lipids, and can involve the elevated synthesis of de novo fatty acids. Ultra-performance liquid chromatography–tandem mass spectrometry (UPLC-MS/MS)-based metabolomics and lipidomics were performed to compare human gastric cancer tissues and adjacent normal tissues from clinical patients. A series of cellular and molecular biological methods were applied to validate the lipidomics results. Palmitic acid (PA) was found to be significantly downregulated in gastric cancer tissues, and it was found that a high concentration of PA specifically inhibited cell proliferation and impaired cell invasiveness and migration in vitro in AGS, SGC-7901, and MGC-803 gastric cancer cell lines. Moreover, sterol regulatory element-binding protein 1 (SREBP-1c) was activated in human gastric cancer tissues, and it promoted the expression of a series of genes associated with the synthesis of fatty acids, such as SCD1 and FASN. SREBP-1c knockdown rescued the migration and invasion defects in AGS and SGC-7901 gastric cancer cells. Taken together, our findings confirmed the variation in fatty acid synthesis in gastric cancer and identified SREBP-1c as a promising target for gastric cancer treatment. [ABSTRACT FROM AUTHOR]